Circular RNA is a popular molecule in tumors of the digestive system (Review)

Hao-Ying Wang1, Yu-Ping Wang1, Xi Zeng1

  • 1Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China.

Insights

Circular RNAs (circRNAs) are non-coding RNAs playing key roles in digestive system cancers. Research highlights their potential as early diagnostic markers for improved patient prognosis in esophageal, gastric, liver, and colorectal malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Digestive system cancers (esophageal, gastric, liver, colorectal) exhibit high morbidity and mortality.
  • Lack of effective early diagnostic methods contributes to poor prognosis in these malignancies.
  • Circular RNAs (circRNAs) are non-coding RNAs with emerging roles in tumorigenesis.

Purpose of the Study:

  • To summarize the biogenesis and function of circRNAs.
  • To review the role of circRNAs in seven common digestive system tumors.
  • To explore the potential of circRNAs as diagnostic markers for digestive system malignancies.

Main Methods:

  • Literature review of circRNA biogenesis and function.
  • Analysis of circRNA involvement in tumorigenesis across seven digestive system cancers.
  • Evaluation of circRNAs as potential diagnostic biomarkers.

Main Results:

  • CircRNAs are increasingly recognized for their significant roles in cancer development.
  • Evidence suggests circRNAs can serve as valuable diagnostic markers for digestive system tumors.
  • Understanding circRNA functions offers insights into cancer progression.

Conclusions:

  • CircRNAs are crucial in the development of digestive system cancers.
  • CircRNAs show promise as novel biomarkers for early cancer detection.
  • Further research into circRNAs can advance the study of digestive system malignancies.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K